| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Dhiren Singh, Daniel W O'Conno. Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia. Clinical interventions in aging. vol 4. 2010-04-07. PMID:19750235. |
efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia. |
2010-04-07 |
2023-08-12 |
Not clear |
| Dhiren Singh, Daniel W O'Conno. Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia. Clinical interventions in aging. vol 4. 2010-04-07. PMID:19750235. |
the available literature revealed that long-acting risperidone is generally well tolerated and is effective in treating both the positive and negative symptoms of schizophrenia. |
2010-04-07 |
2023-08-12 |
Not clear |
| Eric Fakra, Pilar Salgado-Pineda, Nathalie Besnier, Jean-Michel Azorin, Olivier Bli. Risperidone versus haloperidol for facial affect recognition in schizophrenia: findings from a randomised study. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. vol 10. issue 4 Pt 3. 2010-03-19. PMID:17853271. |
risperidone versus haloperidol for facial affect recognition in schizophrenia: findings from a randomised study. |
2010-03-19 |
2023-08-12 |
Not clear |
| Henrik Lublin, Hans-Joachim Haug, Hannu Koponen, Thordur Sigmundsson, Stefan A Kol. Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. vol 10. issue 4 Pt 3. 2010-03-19. PMID:18803070. |
ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial. |
2010-03-19 |
2023-08-12 |
Not clear |
| Sang-Hyuk Lee, Tae Kyou Choi, Shinyoung Suh, Yong Woo Kim, Borah Kim, Eunhee Lee, Ki Hwan Yoo. Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection. Psychiatry research. vol 175. issue 3. 2010-03-16. PMID:20022120. |
effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection. |
2010-03-16 |
2023-08-12 |
Not clear |
| Sang-Hyuk Lee, Tae Kyou Choi, Shinyoung Suh, Yong Woo Kim, Borah Kim, Eunhee Lee, Ki Hwan Yoo. Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection. Psychiatry research. vol 175. issue 3. 2010-03-16. PMID:20022120. |
we examined whether combined therapy with a psychosocial intervention for relapse prevention (pirp) and risperidone administered by long-acting injection (rlai) would be more effective in reducing relapses than rlai with treatment-as-usual (tau) among outpatients with schizophrenia. |
2010-03-16 |
2023-08-12 |
Not clear |
| Sophie Rémillard, Emmanuelle Pourcher, Henri Cohe. Long-term skill proceduralization in schizophrenia. Journal of the International Neuropsychological Society : JINS. vol 16. issue 1. 2010-03-02. PMID:19900349. |
previous studies had revealed no specific effect under haloperidol (typical) and risperidone (atypical) neuroleptic (nlp) treatments for schizophrenia (sz) on a variety of neurocognitive functions relying on the dopaminergic meso-cortico-limbic system (rémillard et al., 2005, 2008). |
2010-03-02 |
2023-08-12 |
human |
| Seetharamaiah Chittiprol, Ganesan Venkatasubramanian, Narendran Neelakantachar, Naveen A Reddy, Kurudunje Taranath Shetty, Bangalore N Gangadha. Longitudinal study of beta2-microglobulin abnormalities in schizophrenia. International immunopharmacology. vol 9. issue 10. 2010-03-01. PMID:19596084. |
compared to baseline, there was a further significant elevation of beta2m in schizophrenia patients following treatment, especially in those who were treated with risperidone. |
2010-03-01 |
2023-08-12 |
Not clear |
| Leslie Citrom. Using oral ziprasidone effectively: the food effect and dose-response. Advances in therapy. vol 26. issue 8. 2010-03-01. PMID:19669631. |
comparisons with other second-generation antipsychotics in meta-analyses reveal similar efficacy to that observed for quetiapine or aripiprazole, but inferior efficacy to that of olanzapine or risperidone in the treatment of schizophrenia. |
2010-03-01 |
2023-08-12 |
Not clear |
| Chris Hawley, Martin Turner, Muhammud A Latif, Vivienne Curtis, Packeruther T Saleem, Kristina Wilto. Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety. Human psychopharmacology. vol 25. issue 1. 2010-03-01. PMID:20041474. |
switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety. |
2010-03-01 |
2023-08-12 |
Not clear |
| Masashi Ikeda, Yasuyuki Tomita, Akihiro Mouri, Minori Koga, Tomo Okochi, Reiji Yoshimura, Yoshio Yamanouchi, Yoko Kinoshita, Ryota Hashimoto, Hywel J Williams, Masatoshi Takeda, Jun Nakamura, Toshitaka Nabeshima, Michael J Owen, Michael C O'Donovan, Hiroyuki Honda, Tadao Arinami, Norio Ozaki, Nakao Iwat. Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches. Biological psychiatry. vol 67. issue 3. 2010-02-25. PMID:19850283. |
identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches. |
2010-02-25 |
2023-08-12 |
mouse |
| Chunbo Li, Jun Xia, Jijun Wan. Risperidone dose for schizophrenia. The Cochrane database of systematic reviews. issue 4. 2010-01-27. PMID:19821422. |
risperidone dose for schizophrenia. |
2010-01-27 |
2023-08-12 |
Not clear |
| Chunbo Li, Jun Xia, Jijun Wan. Risperidone dose for schizophrenia. The Cochrane database of systematic reviews. issue 4. 2010-01-27. PMID:19821422. |
risperidone is a widely used antipsychotic drug for people with schizophrenia. |
2010-01-27 |
2023-08-12 |
Not clear |
| Isabel Martinez-Gras, Gabriel Rubio, Blanca Alvarez del Manzano, Roberto Rodriguez-Jimenez, Fernando Garcia-Sanchez, Alexandra Bagney, Juan Carlos Leza, José Borrel. The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone. Schizophrenia research. vol 115. issue 2-3. 2010-01-25. PMID:19846280. |
the relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone. |
2010-01-25 |
2023-08-12 |
human |
| Isabel Martinez-Gras, Gabriel Rubio, Blanca Alvarez del Manzano, Roberto Rodriguez-Jimenez, Fernando Garcia-Sanchez, Alexandra Bagney, Juan Carlos Leza, José Borrel. The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone. Schizophrenia research. vol 115. issue 2-3. 2010-01-25. PMID:19846280. |
this longitudinal within-subjects test-retest study was designed to evaluate changes in ppi and clinical symptoms in patients with schizophrenia after switching from the conventional antipsychotic zuclopenthixol to long-acting injectable risperidone. |
2010-01-25 |
2023-08-12 |
human |
| Isabel Martinez-Gras, Gabriel Rubio, Blanca Alvarez del Manzano, Roberto Rodriguez-Jimenez, Fernando Garcia-Sanchez, Alexandra Bagney, Juan Carlos Leza, José Borrel. The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone. Schizophrenia research. vol 115. issue 2-3. 2010-01-25. PMID:19846280. |
ppi was measured in 45 chronic male patients with schizophrenia treated with zuclophentixol depot (session t1), and 12 weeks after switching to long-acting injectable risperidone (session t2). |
2010-01-25 |
2023-08-12 |
human |
| Isabel Martinez-Gras, Gabriel Rubio, Blanca Alvarez del Manzano, Roberto Rodriguez-Jimenez, Fernando Garcia-Sanchez, Alexandra Bagney, Juan Carlos Leza, José Borrel. The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone. Schizophrenia research. vol 115. issue 2-3. 2010-01-25. PMID:19846280. |
patients with schizophrenia showed a significant improvement in ppi after changing to long-acting risperidone. |
2010-01-25 |
2023-08-12 |
human |
| Isabel Martinez-Gras, Gabriel Rubio, Blanca Alvarez del Manzano, Roberto Rodriguez-Jimenez, Fernando Garcia-Sanchez, Alexandra Bagney, Juan Carlos Leza, José Borrel. The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone. Schizophrenia research. vol 115. issue 2-3. 2010-01-25. PMID:19846280. |
our findings indicate that long-acting risperidone improves ppi deficits in subjects with chronic schizophrenia. |
2010-01-25 |
2023-08-12 |
human |
| Y C Liu, C L Huang, P L Wu, Y C Chang, C H Huang, H Y Lan. Lack of association between AKT1 variances versus clinical manifestations and social function in patients with schizophrenia. Journal of psychopharmacology (Oxford, England). vol 23. issue 8. 2010-01-12. PMID:18635704. |
these results suggest that akt1 does not play a significant role in clinical and functional manifestations in patients with schizophrenia who receive risperidone treatment. |
2010-01-12 |
2023-08-12 |
Not clear |
| Michael P Caligiuri, Hans-Leo Teulings, Charles E Dean, Alexander B Niculescu, James Loh. Handwriting movement analyses for monitoring drug-induced motor side effects in schizophrenia patients treated with risperidone. Human movement science. vol 28. issue 5. 2010-01-08. PMID:19692133. |
handwriting movement analyses for monitoring drug-induced motor side effects in schizophrenia patients treated with risperidone. |
2010-01-08 |
2023-08-12 |
human |